Abeona Therapeutics Inc. (ABEO): Operating Cash Flow
-$76.33M
Year ended 2025-12-31
-$76.44M
Trailing 12 months to 2026-06-30
| Period ended | Operating Cash Flow | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | -$76.33M | n/m | 2026-03-17, From 2025-01-01 |
| 2024-12-31 | -$56.02M | n/m | 2026-03-17, From 2024-01-01 |
| 2023-12-31 | -$37.01M | n/m | 2025-03-20, From 2023-01-01 |
| 2022-12-31 | -$43.48M | n/m | 2024-03-18, From 2022-01-01 |
| 2021-12-31 | -$65.67M | n/m | 2023-03-29, From 2021-01-01 |
| 2020-12-31 | -$35.02M | n/m | 2022-03-31, From 2020-01-01 |
| 2019-12-31 | -$62.82M | n/m | 2021-03-24, From 2019-01-01 |
| 2018-12-31 | -$39.11M | n/m | 2020-03-16, From 2018-01-01 |
| 2017-12-31 | -$22.66M | n/m | 2020-03-16, From 2017-01-01 |
| 2016-12-31 | -$13.01M | n/m | 2019-03-18, From 2016-01-01 |
| 2015-12-31 | -$10.42M | n/m | 2017-03-30, From 2015-01-01 |
| 2014-12-31 | -$1.61M | n/m | 2016-03-30, From 2014-01-01 |
| 2013-12-31 | $1.0K | n/m | 2014-03-26, From 2013-01-01 |
| 2012-12-31 | -$3.96M | n/m | 2014-03-26, From 2012-01-01 |
| 2011-12-31 | -$7.61M | n/m | 2013-03-20, From 2011-01-01 |
| 2010-12-31 | -$6.86M | n/a | 2012-03-23, From 2010-01-01 |
Operating Cash Flow at similar companies
| Company | Year ended | Operating Cash Flow | Change YoY |
|---|---|---|---|
| Abeona Therapeutics Inc. (ABEO) | 2025-12-31 | -$76.33M | n/m |
| Siga Technologies Inc (SIGA) | 2025-12-31 | $43.47M | -10.8% |
| Puma Biotechnology, Inc. (PBYI) | 2025-12-31 | $41.80M | +7.4% |
| Evommune, Inc. (EVMN) | 2025-12-31 | -$76.44M | n/m |
| Pliant Therapeutics, Inc. (PLRX) | 2025-12-31 | -$128.34M | n/m |
| Evolus, Inc. (EOLS) | 2025-12-31 | -$42.27M | n/m |
| Design Therapeutics, Inc. (DSGN) | 2025-12-31 | -$54.36M | n/m |
| COMPASS Pathways plc (CMPS) | 2025-12-31 | -$157.24M | n/m |
| Oramed Pharmaceuticals Inc. (ORMP) | 2025-12-31 | -$9.14M | n/m |
Compare ABEO, SIGA, PBYI, EVMN side by side · Screen every company in Pharmaceutical Preparations ↗